Dual growth factor delivery to achieve therapeutic neovascularization
Dual growth factor delivery to achieve therapeutic neovascularization
批准号:
0853996
负责人:
Laura Suggs
金额:
$30.0万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-15 至 2012-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5)0853996SuggsThe goal of the PI is to make a significant contribution in cardiovascular tissue engineering though research, education, and the transformation of stem cell engineering. In this context, stem cell engineering includes the design of cell and drug delivery constructs for regenerative medicine and the elucidation of fundamental scientific principles underlying cell-mediated repair. The objective of this proposal is to create a cell-free, dual growth factor delivery system to recruit endogenous progenitors and promote their long-term survival as well as to test the efficacy of this combination strategy in promoting neovascularization and improving cardiac function. The success of this proposal would enable the PI to establish a program in the area of cardiac engineering with a particular focus on designing cell and drug delivery systems. Cardiac stem cell therapy has demonstrated limited efficacy in clinical trials, but will only become a reality through robust cell engineering processes. This approach has the potential to transform stem cell therapy through harnessing the body's own stem cells. Furthermore, the PI's engineering approach will be used as a platform around which a series of educational and outreach goals will be met.Intellectual Merit: Progress in engineering novel techniques for scaffold synthesis and processing may allow for entry into the new phase of cardiac therapy. Natural and synthetic matrices have shown promise as tools to deliver growth factors and cells; however, to date none of these constructs have exhibited the necessary temporal and spatial control. The combination of delivering multiple growth factors to provide mobilization and survival of resident stem cells in a precisely organized presentation provides a realistic solution to the challenge of cardiac therapy. The PI will investigate whether the system can deliver multiple growth factors with controlled release kinetics. The efficacy of a combination strategy (synergistic stem cell recruitment and sustained cell viability) will be evaluated, and the underlying mechanisms will be explored. Broader Impact: The promise of cardiac regeneration can only be realized through solutions engineered on a molecular and cellular level. It is a goal of the current project to serve two functions: (1) to design a unique delivery platform from which stem cell organization can be controlled and (2) to elucidate fundamental mechanisms underlying cell-mediated cardiac repair. The educational and outreach goals are tightly linked via the ideological concept of engineering design. As a junior faculty, the PI has conceived of and implemented the entire BME senior design sequence at UT Austin. She has a strong and continuing passion for design and its instruction and proposes that design should be integrated at all educational levels. The outreach activities described in this proposal extend from pre-college through the level of the undergraduate student. Specific tools will be developed including teaching modules, online course resources, as well as instructional tools for use by existing pre-college outreach programs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Depsipeptides as Tissue Engineering Scaffolds
-
批准号:1609212
-
项目类别:Continuing Grant
-
资助金额:$38.98万
-
财政年份:2016
-
负责人:Laura Suggs
-
依托单位:
CAREER: Designing Embryonic Stem Cell Culture Systems Based on Developmental Microenvironments in the Heart
-
批准号:0845239
-
项目类别:Continuing Grant
-
资助金额:$40.0万
-
财政年份:2009
-
负责人:Laura Suggs
-
依托单位:
ADVANCE Fellows Award: The Development of a Tissue-Engineered Vascular Graft from Multipotent Adult Progenitor Cells
-
批准号:0433745
-
项目类别:Standard Grant
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:Laura Suggs
-
依托单位:
ADVANCE Fellows Award: The Development of a Tissue-Engineered Vascular Graft from Multipotent Adult Progenitor Cells
-
批准号:0137590
-
项目类别:Standard Grant
-
资助金额:$45.65万
-
财政年份:2002
-
负责人:Laura Suggs
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
基于 Klotho 调控 FGF23/SGK1/NF-κB信号通路研究糖尿病肾病血管钙化机制及肾元颗粒干预作用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:
-
依托单位:
非经典TGF-beta信号通路调控小肠干细胞稳态的作用及机制研究
-
批准号:32000538
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:刘连胜
-
依托单位:
mTOR信号通路关键调节蛋白Rheb临近蛋白的筛选及其在细胞衰老中的功能研究
-
批准号:32070778
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:吴苏
-
依托单位:
IQGAP2蛋白在介导R-spondin影响小肠干细胞稳态的作用
-
批准号:31900550
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:刘媛
-
依托单位:
细胞膜受体调控mTORC2活化的新机制研究
-
批准号:31970717
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:罗永挺
-
依托单位:
CD4+CD25+调节性T细胞对肿瘤干细胞的影响及其调控机制研究
-
批准号:81171983
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:李慧
-
依托单位:
尾加压素II在心房纤维化中的作用及机制
-
批准号:81000052
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:史力斌
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位:
逆境胁迫诱导构巢曲霉RAM缺失菌株极性生长恢复的转录调控机制研究
-
批准号:31070031
-
项目类别:面上项目
-
资助金额:40.0万元
-
批准年份:2010
-
负责人:陆玲
-
依托单位: